Aster Al Raffah Walk Again launch advanced Robotic Rehabilitation Centre
A state-of-the-art facility launched by Aster Al Raffah Hospitals & Clinics, set to revolutionize advanced neuro-rehabilitation in Oman, GCC & the African countries.
Muscat – Aster Al Raffah Hospitals & Clinics, a leading integrated healthcare provider under Aster DM Healthcare in the GCC, has officially launched the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre. Located in Ghubra, Muscat, this first-of-its-kind facility in the Sultanate marks a significant milestone in healthcare innovation, poised to transform neuro-rehabilitation across the region.
The facility was inaugurated by His Excellency Dr. Ahmed bin Salim al Mandhari, Undersecretary for Planning and Health Regulation, Ministry of Health, Sultanate of Oman, alongside, Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics – UAE, Oman, Bahrain, Shailesh Guntu, Deputy CEO of Aster Hospitals, UAE & Oman, Rahul Kadavakolu, Group Chief Marketing Officer, Aster DM Healthcare, Dr. Sachin Kandhari, CEO of Walk Again India, and other distinguished guests.
Aster Al Raffah Walk Again is Oman's one of the first private hospital to introduce a specialised robotic rehabilitation facility. It offers a multidisciplinary approach to recovery, utilising advanced robotic technologies to support patients with neurological, spinal, stroke-related, and sports injuries. Spanning three floors, the centre provides specialized rehabilitation for a wide range of conditions, including stroke, spinal cord injury (SCI), traumatic brain injury (TBI), cerebral palsy, multiple sclerosis, and motor neuron diseases, among others. The facility serves both pediatric and adult patients, with provisions for international care.
The centre is designed as a multidisciplinary facility of excellence, specializing in Neurology, Spine, and Sports Medicine, ensuring holistic care for patients recovering from complex injuries and neurological disorders.
A key highlight of the centre is the Cyberdyne HAL, a robotic exoskeleton that assists patients with mobility impairments, enabling walking and limb movement by interpreting bioelectric signals from muscles. Other cutting-edge technologies include the Recoverix Pro system, which uses Brain-Computer Interface (BCI) for stroke and multiple sclerosis rehabilitation, and Vibramoov, a vibration therapy system that enhances gait and mobility. Additional innovations such as Luna EMG, a neurorehabilitation system, and Meissa OT, a robotic upper limb rehabilitation device, ensure comprehensive recovery for patients with varied needs.
The centre also offers advanced neuromodulation treatments, including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for treatment-resistant epilepsy. These technologies, along with Functional Electrical Stimulation, enhance muscle strength and coordination, supporting patients in regaining independence.
The Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre is supported by a team of nationally and internationally recognized specialists in Neurosciences, Orthopedics, Spine, and Rheumatology. Leading the clinical team is Dr. Ali Al Balushi, Consultant – Vascular Neurologist & Neurointerventionalist at Aster Al Raffah Hospitals & Clinics, along with other esteemed doctors who bring extensive expertise in managing complex neurological and musculoskeletal conditions.
By focusing on neuroplasticity, the process through which the brain reorganizes itself after injury, the Aster Al Raffah Walk Again Hospital facilitates recovery through a range of therapies tailored to individual needs. Utilizing US FDA-approved technologies, the centre aims to harness the brain's ability to form new neural connections, a critical element of rehabilitation following neurological conditions.
His Excellency Dr. Ahmed Bin Salim Al Mandhari – Undersecretary for Planning & Health Regulation, Ministry of Health, Sultanate of Oman, speaking about the launch, remarked, 'We are proud to inaugurate this world-class facility in Oman, which will help bring advanced rehabilitation care closer to home for our people. The launch of the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation hospital reflects our vision of building Oman as a leading hub for innovative healthcare. The Government of Oman and the Ministry of Health will continue to partner closely with the private health sector to ensure their success and to bring the best medical technologies to our country for the welfare of our people. This state-of-the-art rehabilitation solution will not only benefit citizens across Oman but will also attract patients from outside Oman, strengthening Oman's position as a destination for world-class treatment.'
Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, commenting on the significance of the initiative, added, 'The Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Hospital is a monumental step forward in providing accessible, world-class rehabilitation care to patients in Oman and the region. This facility is part of Aster's commitment to offering innovative healthcare solutions, and it will undoubtedly transform the lives of patients by offering hope and enabling recovery that was once thought impossible. Through our 'Treat in Oman' initiative, we aim to eliminate the need for residents to travel abroad for advanced care, making Oman a global leader in healthcare excellence.'
Ms. Alisha Moopen, Managing Director & Group CEO of Aster DM Healthcare, commented, 'The launch of the Advanced Robotic Rehabilitation Hospital in Oman marks a defining moment in our mission to make cutting-edge, patient-centric care accessible to all. At Aster, we believe in transforming lives through innovation and compassion. This facility embodies that vision, providing hope and advanced recovery solutions to patients with neurological and musculoskeletal conditions. As we expand our footprint in Oman, we remain committed to raising the bar for specialized care and making the country a leading destination for healthcare excellence in the region.'
Dr. Sachin Kandhari, CEO of Walk Again India, reflecting on the collaboration, said, 'As a leading provider of neuro-rehabilitation, Walk Again is excited to partner with Aster in bringing advanced robotic rehabilitation to Oman. Our mission is to help patients recover from spinal cord injuries, stroke, and other neurological disorders. Through this Hospital, we are committed to leveraging state-of-the-art technology and global expertise to provide the highest standards of care.'
Walk Again brings a legacy of clinical excellence in neuro-rehabilitation, with a strong track record of integrating robotics with personalized treatment protocols. Through the technologies and expertise introduced at the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Hospital, patients in Oman now have access to globally benchmarked rehabilitation solutions without the need to travel abroad.
In addition to clinical services, the centre is committed to advancing medical education and clinical research. It will actively engage in national and international conferences, further establishing its role as a leader in neuro-rehabilitation and innovation. This initiative significantly enhances Oman's healthcare sector and contributes to the Sultanate's broader vision of providing high-quality medical technologies and specialized services closer to home. As a regional centre of excellence, the facility is also expected to attract patients from across the GCC and African nations seeking advanced robotic rehabilitation. Through robotic rehabilitation, the centre aims to empower patients, helping them regain independence and improve their quality of life.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Observer
25-05-2025
- Observer
A plan to end malaria in Africa
Despite being preventable and curable, malaria has continued to claim African lives. In 2023, the continent accounted for around 95 per cent of the 597,000 deaths from malaria worldwide, 76 per cent of which were children under the age of five. But eliminating this scourge, which impedes development goals and realisation of the African Union's Agenda 2063, is within reach. Nine AU member countries – Algeria, Cabo Verde, Egypt, Lesotho, Libya, Mauritius, Morocco, the Seychelles and Tunisia – have become malaria-free, owing to sustained political commitment and well-targeted public investment in primary healthcare and disease surveillance and case management. African countries with a higher malaria burden should heed their example. Algeria, for example, invested in effective vector control through indoor residual spraying, universal healthcare access for malaria diagnosis and treatment, and rapid outbreak-response mechanisms. Cabo Verde's strategic malaria-elimination plan involved a multisectoral approach, whereby the government worked closely with local communities and international organisations. Egypt's multipronged strategy included, among other things, robust training programmes for primary health workers. Implementing these coordinated interventions required the political will and, crucially, increased domestic financing. Overall, Africa's efforts to control malaria – particularly through the use of insecticide-treated nets, indoor spraying and seasonal chemoprevention (which involves giving children a monthly course of antimalarial medicines) – have driven a notable decline in malaria deaths on the continent, from 805,000 in 2000 to 569,000 in 2023. (The Covid-19 pandemic, coupled with the emergence of partial resistance to the well-established malaria medicine artemisinin, caused a brief uptick, to 598,000, in 2020.) But these gains are fragile, particularly as new mosquito variants emerge, insecticide resistance grows, climate change worsens, humanitarian crises become more frequent, and, perhaps most importantly, the global malaria-funding gap widens. In 2023, only $4 billion was mobilised for malaria elimination, far below the $8.3 billion annual target, and a slight drop from the $4.1 billion raised in 2022. The problem is even more acute in Africa, where external health aid has declined by a whopping 70 per cent between 2021 and 2025. Moreover, most African countries devote less than 10 per cent of their national budgets to the health sector – well below the 15 per cent target set by the 2001 Abuja Declaration. Given the uncertain future of foreign aid, African governments must recognise malaria as a development priority and invest more in efforts to control and eliminate it. That means leveraging untapped resources, including the more than $95 billion in annual remittances from the African diaspora. Innovative financing instruments such as diaspora bonds could support the continent's public-health agenda. Solidarity levies on tobacco, mobile transactions, and airline tickets could also generate billions of dollars for health services. And scaling up national health-insurance schemes will be required to expand access to malaria prevention, diagnosis and treatment. Blended finance can unlock private capital for malaria-related research and development, as well as local manufacturing of therapeutics. With Africa's healthcare market projected to be worth $259 billion by 2030, policymakers should capitalise on this opportunity to create effective public-private partnerships, advance last-mile delivery solutions, and improve surveillance and vector control. This would be an investment in Africa's present and future, because every dollar spent on malaria control and elimination generates a remarkable return of $36 in economic growth. A malaria-free population is more likely to access education and contribute to the continent's socioeconomic development. And let me be clear: investing in the fight to end malaria is not only a health and economic imperative; it is an act of justice. The disease disproportionately affects the poorest and most vulnerable Africans, perpetuating cycles of poverty and inequality. Last year, I joined health ministers from 11 AU member countries with high malaria burdens in committing to accelerate efforts to reduce deaths from the disease. As part of the declaration, we agreed that 'no one should die from malaria given the tools and systems available.' The task now is to take concrete action. The Africa Centers for Disease Control and Prevention (of which I am Director-General) is ready to help develop a continental strategy for ending malaria in Africa by 2040. By making smart investments, implementing well-targeted policies and deepening collaboration, we can ensure that all African countries become malaria-free within the coming generation. @Project Syndicate, 2025 Jean Kaseya The writer is Director-General of the Africa Centers for Disease Control and Prevention
Muscat Daily
13-05-2025
- Muscat Daily
Aster Al Raffah Walk Again launch advanced Robotic Rehabilitation Centre
A state-of-the-art facility launched by Aster Al Raffah Hospitals & Clinics, set to revolutionize advanced neuro-rehabilitation in Oman, GCC & the African countries. Muscat – Aster Al Raffah Hospitals & Clinics, a leading integrated healthcare provider under Aster DM Healthcare in the GCC, has officially launched the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre. Located in Ghubra, Muscat, this first-of-its-kind facility in the Sultanate marks a significant milestone in healthcare innovation, poised to transform neuro-rehabilitation across the region. The facility was inaugurated by His Excellency Dr. Ahmed bin Salim al Mandhari, Undersecretary for Planning and Health Regulation, Ministry of Health, Sultanate of Oman, alongside, Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics – UAE, Oman, Bahrain, Shailesh Guntu, Deputy CEO of Aster Hospitals, UAE & Oman, Rahul Kadavakolu, Group Chief Marketing Officer, Aster DM Healthcare, Dr. Sachin Kandhari, CEO of Walk Again India, and other distinguished guests. Aster Al Raffah Walk Again is Oman's one of the first private hospital to introduce a specialised robotic rehabilitation facility. It offers a multidisciplinary approach to recovery, utilising advanced robotic technologies to support patients with neurological, spinal, stroke-related, and sports injuries. Spanning three floors, the centre provides specialized rehabilitation for a wide range of conditions, including stroke, spinal cord injury (SCI), traumatic brain injury (TBI), cerebral palsy, multiple sclerosis, and motor neuron diseases, among others. The facility serves both pediatric and adult patients, with provisions for international care. The centre is designed as a multidisciplinary facility of excellence, specializing in Neurology, Spine, and Sports Medicine, ensuring holistic care for patients recovering from complex injuries and neurological disorders. A key highlight of the centre is the Cyberdyne HAL, a robotic exoskeleton that assists patients with mobility impairments, enabling walking and limb movement by interpreting bioelectric signals from muscles. Other cutting-edge technologies include the Recoverix Pro system, which uses Brain-Computer Interface (BCI) for stroke and multiple sclerosis rehabilitation, and Vibramoov, a vibration therapy system that enhances gait and mobility. Additional innovations such as Luna EMG, a neurorehabilitation system, and Meissa OT, a robotic upper limb rehabilitation device, ensure comprehensive recovery for patients with varied needs. The centre also offers advanced neuromodulation treatments, including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for treatment-resistant epilepsy. These technologies, along with Functional Electrical Stimulation, enhance muscle strength and coordination, supporting patients in regaining independence. The Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre is supported by a team of nationally and internationally recognized specialists in Neurosciences, Orthopedics, Spine, and Rheumatology. Leading the clinical team is Dr. Ali Al Balushi, Consultant – Vascular Neurologist & Neurointerventionalist at Aster Al Raffah Hospitals & Clinics, along with other esteemed doctors who bring extensive expertise in managing complex neurological and musculoskeletal conditions. By focusing on neuroplasticity, the process through which the brain reorganizes itself after injury, the Aster Al Raffah Walk Again Hospital facilitates recovery through a range of therapies tailored to individual needs. Utilizing US FDA-approved technologies, the centre aims to harness the brain's ability to form new neural connections, a critical element of rehabilitation following neurological conditions. His Excellency Dr. Ahmed Bin Salim Al Mandhari – Undersecretary for Planning & Health Regulation, Ministry of Health, Sultanate of Oman, speaking about the launch, remarked, 'We are proud to inaugurate this world-class facility in Oman, which will help bring advanced rehabilitation care closer to home for our people. The launch of the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation hospital reflects our vision of building Oman as a leading hub for innovative healthcare. The Government of Oman and the Ministry of Health will continue to partner closely with the private health sector to ensure their success and to bring the best medical technologies to our country for the welfare of our people. This state-of-the-art rehabilitation solution will not only benefit citizens across Oman but will also attract patients from outside Oman, strengthening Oman's position as a destination for world-class treatment.' Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, commenting on the significance of the initiative, added, 'The Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Hospital is a monumental step forward in providing accessible, world-class rehabilitation care to patients in Oman and the region. This facility is part of Aster's commitment to offering innovative healthcare solutions, and it will undoubtedly transform the lives of patients by offering hope and enabling recovery that was once thought impossible. Through our 'Treat in Oman' initiative, we aim to eliminate the need for residents to travel abroad for advanced care, making Oman a global leader in healthcare excellence.' Ms. Alisha Moopen, Managing Director & Group CEO of Aster DM Healthcare, commented, 'The launch of the Advanced Robotic Rehabilitation Hospital in Oman marks a defining moment in our mission to make cutting-edge, patient-centric care accessible to all. At Aster, we believe in transforming lives through innovation and compassion. This facility embodies that vision, providing hope and advanced recovery solutions to patients with neurological and musculoskeletal conditions. As we expand our footprint in Oman, we remain committed to raising the bar for specialized care and making the country a leading destination for healthcare excellence in the region.' Dr. Sachin Kandhari, CEO of Walk Again India, reflecting on the collaboration, said, 'As a leading provider of neuro-rehabilitation, Walk Again is excited to partner with Aster in bringing advanced robotic rehabilitation to Oman. Our mission is to help patients recover from spinal cord injuries, stroke, and other neurological disorders. Through this Hospital, we are committed to leveraging state-of-the-art technology and global expertise to provide the highest standards of care.' Walk Again brings a legacy of clinical excellence in neuro-rehabilitation, with a strong track record of integrating robotics with personalized treatment protocols. Through the technologies and expertise introduced at the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Hospital, patients in Oman now have access to globally benchmarked rehabilitation solutions without the need to travel abroad. In addition to clinical services, the centre is committed to advancing medical education and clinical research. It will actively engage in national and international conferences, further establishing its role as a leader in neuro-rehabilitation and innovation. This initiative significantly enhances Oman's healthcare sector and contributes to the Sultanate's broader vision of providing high-quality medical technologies and specialized services closer to home. As a regional centre of excellence, the facility is also expected to attract patients from across the GCC and African nations seeking advanced robotic rehabilitation. Through robotic rehabilitation, the centre aims to empower patients, helping them regain independence and improve their quality of life.
Times of Oman
25-04-2025
- Times of Oman
Increases in vaccine-preventable disease outbreaks threaten years of progress, warn WHO, UNICEF, Gavi
Geneva: Immunisation efforts are increasingly at risk as misinformation, population growth, ongoing humanitarian crises, and funding cuts jeopardise progress and leave millions of children, adolescents, and adults at risk, warned WHO, UNICEF, and Gavi during World Immunisation Week (April 24-30). Outbreaks of vaccine-preventable diseases such as measles, meningitis, and yellow fever are rising globally, and diseases like diphtheria, which have long been held at bay or virtually disappeared in many countries, are at risk of re-emerging. In response, the agencies are calling for urgent and sustained political attention and investment to strengthen immunisation programmes and protect significant progress achieved in reducing child mortality over the past 50 years. "Vaccines have saved more than 150 million lives over the past five decades," said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. "Funding cuts to global health have put these hard-won gains in jeopardy. Outbreaks of vaccine-preventable diseases are increasing around the world, putting lives at risk and exposing countries to increased costs in treating diseases and responding to outbreaks. Countries with limited resources must invest in the highest-impact interventions - and that includes vaccines." Measles is making an especially dangerous comeback. The number of cases has been increasing year on year since 2021, tracking the reductions in immunisation coverage that occurred during and since the COVID-19 pandemic in many communities. Measles cases reached an estimated 10.3 million in 2023, representing a 20% increase from 2022. The agencies warn that this upward trend is likely to continue into 2024 and 2025, as outbreaks have intensified worldwide. In the past 12 months, 138 countries have reported measles cases, with 61 experiencing large or disruptive outbreaks -- the highest number observed in any 12-month period since 2019. Meningitis cases in Africa also rose sharply in 2024, and the upward trend has continued into 2025. In the first three months of this year alone, more than 5500 suspected cases and nearly 300 deaths were reported in 22 countries. This follows approximately 26,000 cases and almost 1400 deaths across 24 countries last year. Yellow fever cases in the African region are also on the rise, with 124 confirmed cases reported in 12 countries as of 2024. This comes after dramatic declines in the disease over the past decade, thanks to global vaccine stockpiles and the use of yellow fever vaccine in routine immunisation programmes. In the WHO Region of the Americas, yellow fever outbreaks have been confirmed since the beginning of the year, with a total of 131 cases reported in four countries. These outbreaks come amidst global funding cuts. A recent WHO rapid stocktake with 108 country offices of WHO, mostly in low- and lower-middle-income countries, shows that nearly half of these countries are facing moderate to severe disruptions to vaccination campaigns, routine immunisation, and access to supplies due to reduced donor funding. Disease surveillance, including for vaccine-preventable diseases, is also impacted in more than half of the countries surveyed. At the same time, the number of children missing routine vaccinations has been increasing in recent years, even as countries make efforts to catch up on children missed during the pandemic. In 2023, an estimated 14.5 million children missed all of their routine vaccine doses--up from 13.9 million in 2022 and 12.9 million in 2019. Over half of these children live in countries facing conflict, fragility, or instability, where access to basic health services is often disrupted. "The global funding crisis is severely limiting our ability to vaccinate over 15 million vulnerable children in fragile and conflict-affected countries against measles," said UNICEF Executive Director Catherine Russell. "Immunisation services, disease surveillance, and outbreak response in nearly 50 countries are already being disrupted, on par with the setbacks we saw during COVID-19. We cannot afford to lose ground in the fight against preventable disease." Continued investment in the 'Big Catch-Up initiative,' launched in 2023 to reach children who missed vaccines during the COVID-19 pandemic, and other routine immunisation programmes will be critical. Joint efforts by WHO, UNICEF, Gavi and partners have helped countries expand access to vaccines and strengthen immunisation systems through primary health care, even in the face of mounting challenges. Every year, vaccines save nearly 4.2 million lives against 14 diseases, with nearly half of these lives saved in the African region. Vaccination campaigns have led to the elimination of meningitis A in Africa's meningitis belt. A new vaccine that protects against five strains of meningitis holds promise for broader protection, with efforts underway to expand its use for outbreak response and prevention. Progress has also been made in reducing yellow fever cases and deaths through increasing routine immunisation coverage and emergency vaccine stockpiles, but recent outbreaks in Africa and in the Region of the Americas highlight the risks in areas with no reported cases in the past, low routine vaccination coverage and gaps in preventive campaigns. In addition, the past two years have seen substantial progress in other areas of immunisation. In the African region, which has the highest cervical cancer burden in the world, HPV vaccine coverage nearly doubled between 2020 and 2023 from 21% to 40%, reflecting a concerted global effort towards eliminating cervical cancer. The progress in immunisation also includes increases in global coverage of pneumococcal conjugate vaccines, particularly in the South-East Asia Region, alongside introductions in Chad and Somalia, countries with high disease burden. Another milestone is the sub-national introduction of malaria vaccines in nearly 20 African countries, laying the foundation to save half a million additional lives by 2035 as more countries adopt the vaccines and scale-up accelerates as part of the tools to fight malaria. UNICEF, WHO, and Gavi urgently call for parents, the public, and politicians to strengthen support for immunisation. The agencies emphasise the need for sustained investment in vaccines and immunisation programmes and urge countries to honour their commitments to the Immunisation Agenda 2030 (IA2030). As part of integrated primary healthcare systems, vaccination can protect against diseases and connect families to other essential care, such as antenatal care, nutrition or malaria screening. Immunisation is a 'best buy' in health with a return on investment of USD 54 for every dollar invested and provides a foundation for future prosperity and health security. "Increasing outbreaks of highly infectious diseases are a concern for the whole world. The good news is we can fight back, and Gavi's next strategic period has a clear plan to bolster our defences by expanding investments in global vaccine stockpiles and rolling out targeted preventive vaccination in countries most impacted by meningitis, yellow fever and measles," said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. "These vital activities, however, will be at risk if Gavi is not fully funded for the next five years and we call on our donors to support our mission in the interests of keeping everyone, everywhere, safer from preventable diseases." Gavi's upcoming high-level pledging summit, taking place on June 25, 2025, seeks to raise at least USD 9 billion from our donors to fund our ambitious strategy to protect 500 million children, saving at least 8 million lives from 2026-2030.
